Tubular antithrombin at transplantation determines subsequent renal allograft function

Transplantation

Volumn 66, Issue 6, 1998, Pages 797-799

  Torry, Ronald J ^a   Labarrere, Carlos A ^a   Nelson, David ^a,b   Carter, Charles ^a   Haag, Brian ^a   Faulk, W Page ^a  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN;

ARTICLE; ASPIRATION BIOPSY; GRAFT REJECTION; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY TUBULE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION;

ANTITHROMBINS; BIOPSY; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; PREDICTIVE VALUE OF TESTS; TRANSPLANTS;

EID: 0032572980     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199809270-00016     Document Type: Article

References (10)

1. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987; 235: 1348.
2. Faulk WP, Labarrere CA. Antithrombin III in normal and transplanted hearts: indications of vascular disease. Semin Hematol 1994; 31: 26.
3. Absher E, Labarrere CA, Carter C, Haag B, Faulk WP. The endothelial heparan sulfate-antithrombin III natural anticoagulant pathway in normal and transplanted human kidneys. Transplantation 1992; 53: 828.
4. Torry RJ, Labarrere CA, Gargiulo P, Faulk WP. Natural anticoagulant and fibrinolytic pathways in renal allograft failure. Transplantation 1994; 58: 926.
5. Faulk WP, Labarrere C. Fibrinolytic and anticoagulant control of hemostasis in human cardiac and renal allografts. In: Hammond EH, ed. Major problems in pathology. Philadelphia: W. B. Saunders, 1994; 30: 49.
6. Moestrup SK, Nielsen S, Andreasen PA, et al. Epithelial glycoprotein 330 mediates endocytosis of plasminogen activator- plasminogen activator inhibitor type-I complexes. J Biol Chem 1993; 268: 16564.
7. Vaziri ND, Gonzales EC, Wang J, Said S. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis. Am J Kidney Dis 1994; 23: 828.
8. Farkas JC, Tabet G, Marzelle J, Cormier F, Laurian C, Cormier JM. Arterial thrombosis: a rare complication of the nephrotic syndrome. Cardiovasc Surg 1993; 1: 265.
9. Shoskes DA, Halloran PF. Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol 1996; 155: 1831.
10. Najarian JS, Gillingham KJ, Sutherland DER, Reinsmoen NL, Payne WD, Matas AJ. The impact of the quality of initial graft function on cadaveric kidney transplants. Transplantation 1994; 57: 812.